Therapeutic targeting: a crucible for individualized medicine (Q81120955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425084 AND SRC:MED&resulttype=core&format=json

6 January 2020

editorial

0 references

title

Therapeutic targeting: a crucible for individualized medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425084 AND SRC:MED&resulttype=core&format=json

6 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425084 AND SRC:MED&resulttype=core&format=json

6 January 2020

author name string

A Terzic

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425084 AND SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425084 AND SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425084 AND SRC:MED&resulttype=core&format=json

6 January 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425084 AND SRC:MED&resulttype=core&format=json

6 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425084 AND SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

651-654

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425084 AND SRC:MED&resulttype=core&format=json

A vision of individualized medicine in the context of global health

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Molecular medicine hones therapeutic arts to science

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Individualized medicine and the imperative of global health.

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Systems biology and new technologies enable predictive and preventative medicine.

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Breakthrough of the year. Human genetic variation

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

The impact of systems approaches on biological problems in drug discovery

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Clinical pharmacology: the science of therapeutics

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

The art and science of personalized medicine

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

The pharmacogenetics research network: from SNP discovery to clinical drug response.

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

The prospects for "personalized medicine" in drug development and drug therapy

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Personalized medicine: elusive dream or imminent reality?

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Medical product development and regulatory science for the 21st century: the critical path vision and its impact on health care

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Paving the critical path: how can clinical pharmacology help achieve the vision?

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Biomarker development, commercialization, and regulation: individualization of medicine lost in translation

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

The ethical implications of stratifying by race in pharmacogenomics

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Benefit and risk assessment in drug development and utilization: a role for clinical pharmacology

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Molecular systems biology in drug development

1 reference

https://api.crossref.org/works/10.1038/CLPT.2008.65

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425084 AND SRC:MED&resulttype=core&format=json

6 January 2020

1 reference